Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06655610. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06655610
External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility study
This study is recruiting. It focuses on ADHD and currently lists participation information in Denmark.
ADHDOtherFrom 7 Years to 17 Years
Key information made simple
This study is looking at whether a digital support tool can help people with ADHD - Attention Deficit Disorder With Hyperactivity. Participants take part in a digital support tool and complete follow-up assessments. Some participants may receive Sham eTNS instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a clinic, with sites including Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, 4200 Slagelse, Denmark in Slagelse. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually meeting the main study requirements and having a stable enough treatment background for the study, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Psychiatric Research Unit, Region Zealand, Denmark
- Sponsor type
- Unknown or unclear
- Main activity
- digital app or tool
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial
- Condition
- ADHD - Attention Deficit Disorder With Hyperactivity
- Study status
- Recruiting
- Sponsor / lead affiliation
- Psychiatric Research Unit, Region Zealand, Denmark
- Location / country
- Denmark
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06655610
Why this study may matter
This study may matter because it adds public evidence around adhd. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Denmark.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06655610
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility study?
This study is exploring digital app or tool for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a sham comparison. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Psychiatric Research Unit, Region Zealand, Denmark. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me